Measuring cancer survival in populations: Relative survival vs cancer-specific survival

International Journal of Epidemiology

Volumn 39, Issue 2, 2010, Pages 598-610

  Sarfati, Diana ^a   Blakely, Tony ^a   Pearce, Neil ^b  

^a UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Cancer; Excess mortality; Relative survival; Survival; Survival analysis

Indexed keywords

CANCER; CAUSE OF DEATH; CLASSIFICATION; COMPARATIVE STUDY; EPIDEMIOLOGY; ESTIMATION METHOD; MORTALITY; POPULATION ESTIMATION; SURVIVAL;

ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; DATA ANALYSIS; EPIDEMIOLOGICAL DATA; HUMAN; INFORMATION PROCESSING; POPULATION RESEARCH; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SURVIVAL RATE; SYSTEMATIC ERROR;

BIAS (EPIDEMIOLOGY); CAUSE OF DEATH; HUMANS; NEOPLASMS; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 77952738521     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp392     Document Type: Article

References (39)

1. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med 2006;260:103-17.
2. Dickman PW, Auvinen A, Voutilainen ET, Hakulinen T. Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study. J Epidemiol Community Health 1998;52:727-34.
3. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51-64.
4. Rachet B, Woods LM, Mitry E et al. Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 2008;99:S2-S10.
5. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley, 1980.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
7. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706.
8. Gamel JW, Vogel RL. Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Stat Methods Med Research 2001;10:339-52.
9. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-35.
10. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978;34: 541-54.
11. Platell CF, Semmens JB. Review of survival curves for colorectal cancer. Dis Colon Rectum 2004;47:2070-75.
12. James DS, Bull AD. Information on death certificates: cause for concern? J Clin Pathol 1996;49:213-16.
13. Maudsley G, Williams EM. "Inaccuracy" in death certification-where are we now? J Public Health Med 1996;18:59-66.
14. Percy C, Stanek E 3rd, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981;71:242-50.
15. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, based on the recommendations of the ninth revision conference, 1975. Geneva: WHO, 1977.
16. Samphier ML, Robertson C, Bloor MJ. A possible artefactual component in specific cause mortality gradients. Social class variations in the clinical accuracy of death certificates. J Epidemiol Community Health 1988;42:138-43.
17. Welch HG, Black WC. Are deaths within 1 month of cancer-directed surgery attributed to cancer? J Natl Cancer Inst 2002;94:1066-70.
18. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst 1993;85: 979-87.
19. Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urology 2000;163:519-23.
20. Goldacre MJ. Cause-specific mortality: understanding uncertain tips of the disease iceberg. J Epidemiol Community Health 1993;47:491-96.
21. Pearce N, Checkoway H, Dement J. Exponential models for analyses of time-related factors, illustrated with asbestos textile worker mortality data. J Occup Med 1988;30:517-22.
22. Rothman K, Greenland S, Lash TL (eds). Modern Epidemiology, 3rd edn. Philadelphia: Lippincott Williams and Wilkins, 2008.
23. Ederer F, Axtell LM, Cutler SJ. The relative survival: a statistical methodology. Natl Cancer Instit Monograph 1961;6:101-21.
24. Ederer F, Heise H. Instructions to IBM 650 Programmers in Processing Survival Computations. Methodolgical Note No. 10. Bethesda, Maryland: End Results Evaluation Section, National Cancer Institute, 1959.
25. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933-42.
26. Baade PD, Fritschi L, Eakin EG. Non-cancer mortality among people diagnosed with cancer (Australia). Cancer Causes Control 2006;17:287-97.
27. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-52.
28. Warburton DER, Nicol CW, Bredin SSD. Health benefits of physical activity: the evidence. CMAJ 2006;174:801-9.
29. Kushi L, Giovannucci E. Dietary fat and cancer. Am J Med 2002;113(Suppl 9B):63S-70S.
30. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Lancet 2002;360:861-68.
31. Hutter RV. Cancer prevention and detection. Status report and future prospects. Cancer 1988;61:2372-78.
32. Blakely T, Sarfati D, Shaw C. What proportion of cancer is due to obesity? NZ Med J 2009;122:3478.
33. Pokhrel A, Hakulinen T. Age-standardisation of relative survival ratios of cancer patients in a comparison between countries, genders and time periods. Eur J Cancer 2009;45: 642-47.
34. Pokhrel A, Hakulinen T. How to interpret the relative survival ratios of cancer patients. Eur J Cancer 2008;44: 2661-67
35. Giorgi R, Hedelin G, Schaffer P. Relative survival: comparison of regressive models and advice for the user. J Epidemiol Biostat 2001;6:455-62.
36. Jeffreys M, Stevanovic S, Tobias M et al. Ethnic differences in cancer survival in New Zealand: linkage study. Am J Public Health 2004;95:834-37.
37. Ajwani S, Blakely T, Robson B, Atkinson J, Kiro C. Unlocking the numerator-denominator bias III: adjustment ratios by ethnicity for 1981-1999 mortality data. The New Zealand Census-Mortality Study. N Z Med J 2003;116:U456.
38. Boer R, Ries L, van Ballegooijen M, Feuer E, Legler J, Habbema D. Ambiguities in Calculating Cancer Patient Survival: The SEER Experience for Colorectal and Prostate Cancer, Technical Report #2003-05. Statistical Research and Applications Branch: National Cancer Institute, 2003.
39. Kravdal O. A cancer survival model that takes sociodemographic variations in "normal" mortality into account: comparison with other models. J Epidemiol Community Health 2002;56:309-18.